Point72 Middle East FZE’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-359,262
Closed -$25.6M 1569
2023
Q3
$25.1M Buy
359,262
+121,871
+51% +$8.64M 0.82% 12
2023
Q2
$16.4M Buy
237,391
+20,259
+9% +$1.44M 0.46% 35
2023
Q1
$16.1M Buy
217,132
+85,207
+65% +$7.15M 0.55% 26
2022
Q4
$12.3M Buy
+131,925
New +$12.7M 0.54% 14

Other funds holding CVS

Point72 Middle East FZE's CVS Position: Q4 2023 in Review

Point72 Middle East FZE sold out of CVS Health (CVS) in Q4 2023, closing a stake of 359,262 shares — an estimated $25.6M sold.

Point72 Middle East FZE first reported a position in CVS in Q4 2022 and held it in 4 quarters. The position peaked at $25.1M in Q3 2023. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Point72 Middle East FZE reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 359,262 CVS Health shares in Q4 2023, an estimated $25.6M.
  • Point72 Middle East FZE first reported a position in CVS Health in Q4 2022 and held it in 4 quarters.
  • Point72 Middle East FZE's CVS Health position peaked at $25.1M in Q3 2023.
  • 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.